Aytu BioPharma (NASDAQ:AYTU) Releases Quarterly Earnings Results, Misses Expectations By $0.37 EPS
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.82) EPS for the quarter, missing the consensus estimate of ($0.45) by ($0.37), Zacks reports. Aytu BioPharma had a negative net margin of 14.60% and a negative return on equity of 31.31%. The firm had revenue of $17.98 […]
28 Sep 13:45 · The Markets Daily